272 related articles for article (PubMed ID: 23124027)
1. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
Piao L; Fang YH; Parikh KS; Ryan JJ; D'Souza KM; Theccanat T; Toth PT; Pogoriler J; Paul J; Blaxall BC; Akhter SA; Archer SL
Circulation; 2012 Dec; 126(24):2859-69. PubMed ID: 23124027
[TBL] [Abstract][Full Text] [Related]
2. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
Ryan JJ; Archer SL
Circ Res; 2014 Jun; 115(1):176-88. PubMed ID: 24951766
[TBL] [Abstract][Full Text] [Related]
3. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.
Piao L; Fang YH; Parikh K; Ryan JJ; Toth PT; Archer SL
J Mol Med (Berl); 2013 Oct; 91(10):1185-97. PubMed ID: 23794090
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.
Piao L; Fang YH; Cadete VJ; Wietholt C; Urboniene D; Toth PT; Marsboom G; Zhang HJ; Haber I; Rehman J; Lopaschuk GD; Archer SL
J Mol Med (Berl); 2010 Jan; 88(1):47-60. PubMed ID: 19949938
[TBL] [Abstract][Full Text] [Related]
5. Targeting neurohumoral signaling to treat pulmonary hypertension: the right ventricle coming into focus.
Maron BA
Circulation; 2012 Dec; 126(24):2806-8. PubMed ID: 23124028
[No Abstract] [Full Text] [Related]
6. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
Fang YH; Piao L; Hong Z; Toth PT; Marsboom G; Bache-Wiig P; Rehman J; Archer SL
J Mol Med (Berl); 2012 Jan; 90(1):31-43. PubMed ID: 21874543
[TBL] [Abstract][Full Text] [Related]
7. Triggering the succinate receptor GPR91 enhances pressure overload-induced right ventricular hypertrophy.
Yang L; Yu D; Fan HH; Feng Y; Hu L; Zhang WY; Zhou K; Mo XM
Int J Clin Exp Pathol; 2014; 7(9):5415-28. PubMed ID: 25337184
[TBL] [Abstract][Full Text] [Related]
8. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
9. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
10. Effects of a pure alpha/beta-adrenergic receptor blocker on monocrotaline-induced pulmonary arterial hypertension with right ventricular hypertrophy in rats.
Ishikawa M; Sato N; Asai K; Takano T; Mizuno K
Circ J; 2009 Dec; 73(12):2337-41. PubMed ID: 19822980
[TBL] [Abstract][Full Text] [Related]
11. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
[TBL] [Abstract][Full Text] [Related]
12. Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction.
Vasudevan NT; Mohan ML; Gupta MK; Martelli EE; Hussain AK; Qin Y; Chandrasekharan UM; Young D; Feldman AM; Sen S; Dorn GW; Dicorleto PE; Naga Prasad SV
Circulation; 2013 Jul; 128(4):377-87. PubMed ID: 23785004
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyocyte-specific overexpression of HEXIM1 prevents right ventricular hypertrophy in hypoxia-induced pulmonary hypertension in mice.
Yoshikawa N; Shimizu N; Maruyama T; Sano M; Matsuhashi T; Fukuda K; Kataoka M; Satoh T; Ojima H; Sawai T; Morimoto C; Kuribara A; Hosono O; Tanaka H
PLoS One; 2012; 7(12):e52522. PubMed ID: 23300697
[TBL] [Abstract][Full Text] [Related]
14. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
[TBL] [Abstract][Full Text] [Related]
15. The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy.
Yang L; Yu D; Mo R; Zhang J; Hua H; Hu L; Feng Y; Wang S; Zhang WY; Yin N; Mo XM
PLoS One; 2016; 11(1):e0147597. PubMed ID: 26824665
[TBL] [Abstract][Full Text] [Related]
16. G alpha(q)-mediated activation of GRK2 by mechanical stretch in cardiac myocytes: the role of protein kinase C.
Malhotra R; D'Souza KM; Staron ML; Birukov KG; Bodi I; Akhter SA
J Biol Chem; 2010 Apr; 285(18):13748-60. PubMed ID: 20194499
[TBL] [Abstract][Full Text] [Related]
17. Effect of p53 activation on experimental right ventricular hypertrophy.
Veeroju S; Mamazhakypov A; Rai N; Kojonazarov B; Nadeau V; Breuils-Bonnet S; Li L; Weissmann N; Rohrbach S; Provencher S; Bonnet S; Seeger W; Schermuly R; Novoyatleva T
PLoS One; 2020; 15(6):e0234872. PubMed ID: 32559203
[TBL] [Abstract][Full Text] [Related]
18. Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
Mendes-Ferreira P; Maia-Rocha C; Adão R; Mendes MJ; Santos-Ribeiro D; Alves BS; Cerqueira RJ; Castro-Chaves P; Lourenço AP; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2016 Jan; 109(1):44-54. PubMed ID: 26503987
[TBL] [Abstract][Full Text] [Related]
19. Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca
Fowler ED; Drinkhill MJ; Norman R; Pervolaraki E; Stones R; Steer E; Benoist D; Steele DS; Calaghan SC; White E
J Mol Cell Cardiol; 2018 Jul; 120():74-83. PubMed ID: 29807024
[TBL] [Abstract][Full Text] [Related]
20. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
